https://www.selleckchem.com/products/ly364947.html
Following power calculations, 60 hospitalised patients and 100 ventilated patients will be recruited to demonstrate a 20% difference. The duration of follow-up is up to the point of discharge. Ethical approval was obtained through the independent Human Research Ethics Committee. Participant recruitment will commence in May 2020. Results will be published in peer-reviewed medical journals. ACTRN126200000454976. ACTRN126200000454976. A proportion of those recovering from COVID-19 are likely to have significant and ongoing symptoms, funct
Like
Comment
Share
